Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy

Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy

The efficacy of omalizumab has been extensively investigated in clinical trials in patients with severe persistent allergic (pre-treatment total immunoglobulin E 30–700 IU·mL–1) asthma including the Investigation of Omalizumab in Severe Asthma Treatment (INNOVATE) study, which enrolled patients with...

Full description

Bibliographic Details
Main Author: R. Buhl
Format: Article
Language:English
Published: European Respiratory Society 2007-09-01
Series:European Respiratory Review
Subjects:
Allergy
anti-immunoglobulin E
asthma
exacerbation
omalizumab
therapy
Online Access:http://err.ersjournals.com/cgi/content/full/16/104/73

Internet

http://err.ersjournals.com/cgi/content/full/16/104/73

Similar Items